Patents by Inventor Aleksandra Franovic

Aleksandra Franovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11918587
    Abstract: Provided herein are compositions and methods for the treatment of a cancer. Said compositions comprise a RAF inhibitor. Some embodiments comprise combination therapy featuring the RAF inhibitor with at least one oncology therapeutic agent.
    Type: Grant
    Filed: April 6, 2023
    Date of Patent: March 5, 2024
    Assignee: KINNATE BIOPHARMA INC.
    Inventors: Aleksandra Franovic, Eric Martin, Nichol L. G. Miller, Eric Murphy, Richard Thomas Williams, Ken Kobayashi
  • Publication number: 20230255977
    Abstract: Provided herein are compositions and methods for the treatment of a cancer. Said compositions comprise a RAF inhibitor. Some embodiments comprise combination therapy featuring the RAF inhibitor with at least one oncology therapeutic agent.
    Type: Application
    Filed: April 6, 2023
    Publication date: August 17, 2023
    Inventors: Aleksandra FRANOVIC, Eric MARTIN, Nichol L. G. MILLER, Eric MURPHY, Richard Thomas WILLIAMS, Ken KOBAYASHI
  • Publication number: 20140154264
    Abstract: In alternative embodiments, the invention provides compositions and methods for identifying individuals that would be responsive to a treatment comprising (including) blocking activation of integrin polypeptide alphav-beta3 (or ?v-?3), or blocking the interaction of a ligand with integrin polypeptide alphav-beta3 (or ?v-?3). The invention provides compositions and methods for determining the effectiveness of such a treatment and can contribute to a prognosis for the patient.
    Type: Application
    Filed: June 1, 2012
    Publication date: June 5, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: David Cheresh, Aleksandra Franovic, Laetitia Seguin